PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling

Mathilde Poulet1,2, Jacinthe Sirois2, Kevin Boyé1

  • 1Univ. Bordeaux, INSERM, LAMC (Laboratoire de l'Angiogenèse et du Microenvironment des Cancers), U1029, F-33600, Pessac, France.

Communications Biology
|October 24, 2020
PubMed

Insights

Protein tyrosine phosphatases regulate blood vessel formation. This study shows Phosphatase of Regenerative Liver-2 (PRL-2) is crucial for developmental angiogenesis, impacting endothelial cell migration and signaling pathways.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Vascular Biology

Background:

  • Protein tyrosine phosphatases (PTPs) are key regulators of cellular processes.
  • Atypical Phosphatase of Regenerative Liver (PRL) phosphatases' role in angiogenesis is largely unknown.
  • Angiogenesis is critical for development and implicated in diseases like cancer.

Purpose of the Study:

  • To investigate the function of PRL phosphatases in developmental angiogenesis.
  • To elucidate the role of PRL-2 (Ptp4a2) in postnatal mouse retinal vascular development.
  • To understand the molecular mechanisms by which PRL-2 influences angiogenesis.

Main Methods:

  • Analysis of inducible endothelial-specific and global Ptp4a2 mutant mice.
  • Assessment of retinal vascular outgrowth, arteriovenous differentiation, and sprouting angiogenesis.
  • Investigation of endothelial cell migration and key signaling pathways (VEGF-A, DLL-4/NOTCH-1).

Main Results:

  • Endothelial cells express PRL-2 in the postnatal retina.
  • Ptp4a2 deficiency in mice led to defective retinal vascular development.
  • PRL-2 deletion impaired endothelial cell migration and inhibited VEGF-A and DLL-4/NOTCH-1 signaling.

Conclusions:

  • PRL-2 is essential for normal developmental angiogenesis.
  • PRL-2 modulates vascular development by influencing endothelial cell migration and signaling.
  • PRL-2 represents a potential therapeutic target in angiogenesis-related conditions.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.6K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.8K
What are Second Messengers?01:12

What are Second Messengers?

Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
88.5K